<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Neale Mahoney | Macro Paper Warehouse</title><link>https://macropaperwarehouse.com/authors/neale-mahoney/</link><description>Neale Mahoney</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><atom:link href="https://macropaperwarehouse.com/authors/neale-mahoney/index.xml" rel="self" type="application/rss+xml"/><item><title>The Effects of Medical Debt Relief: Evidence from Two Randomized Experiments</title><link>https://macropaperwarehouse.com/papers/the-effects-of-medical-debt-relief-evidence-from-two-randomized-experiments/</link><guid>https://macropaperwarehouse.com/papers/the-effects-of-medical-debt-relief-evidence-from-two-randomized-experiments/</guid><description>&lt;p&gt;&lt;strong&gt;Research Question&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;This paper asks whether relieving downstream medical debt — debt that has been sold to third-party debt collectors — causes improvements in financial outcomes, mental and physical health, and healthcare utilization for recipients. The question is motivated by a large correlational literature documenting strong associations between medical debt and adverse outcomes, and by the rapid expansion of government and private debt relief programs that, as of mid-2024, had committed or planned over $14.6 billion in relief.&lt;/p&gt;</description></item></channel></rss>